A new coronavirus variant found in New York City

People wait in line to receive Pfizer's COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, Feb 23, 2021. [Photo/Agencies]

A new coronavirus variant is spreading rapidly in New York City and in the Northeast and could dampen the effectiveness of some current vaccine candidates, according to researchers.

The new variant, called B.1.526, carries mutations that help the virus dodge the body's natural immune response and the effects of monoclonal antibody treatment. It was identified by teams at the University of California (Caltech) and Columbia.

In connection with new variant strains, Pfizer and BioNTech said Thursday they have begun a study to test whether a third dose of their authorized vaccine would fight new strains, such as the one first identified in South Africa.

Earlier studies found that both the Pfizer-BioNTech and Moderna Covid-19 vaccines offer less protection against the South African strain. Moderna said Wednesday it had made a new version of its vaccine targeting the South Africa strain.

The research group at Caltech scanned for mutations among hundreds of thousands of COVID-19 genetic sequences in GISAID, a database shared by scientists. It discovered that the new variant first appeared in samples collected in New York City in November. By the middle of this month, the Caltech team found that the number of B.1.526 cases had risen to about 27 percent of viral sequences appearing in the database.

In the other study, researchers at Columbia University analyzed 1,142 samples from patients at the school's hospital and found that more than 12 percent of people with coronavirus had been infected with the variant.

"We observed a steady increase in the detection rate from late December to mid-February, with an alarming rise to 12.3 percent in the past two weeks," wrote one team at the Columbia University Medical Center in a report published Thursday at MedRxiv, a website that allows new research to be shared before its formal publication.

"Patients with this novel variant came from diverse neighborhoods in the metropolitan area, and they were on average older and more frequently hospitalized," the team said in the report.

Dr David Ho, one of the researchers on the Columbia team, noted cases in Westchester, in the Bronx and Queens, the lower part of Manhattan and in Brooklyn and that there is some level of community spread involving the new variant. "It seems to be widespread. It's not a single outbreak," he told The New York Times.

"It's not particularly happy news," Michel Nussenzweig, an immunologist at New York's Rockefeller University, told the Times, adding that people who have recovered from the coronavirus or who have been vaccinated are "very likely to be able to fight this variant off, there's no doubt about that".

The research from the teams at Caltech and Columbia hasn't been peer-reviewed or published in a scientific journal.

New research suggests that a variant identified in California in December, known to scientists as B.1.427/B.1.429, is more contagious than earlier forms of the coronavirus.

California passed the 50,000-death mark from COVID-19 on Wednesday, the most of any state. The new study helped explain the state's dramatic surge in cases and deaths, according to health experts.

The new coronavirus strain now dominant in California is associated with more severe illness and death and also can evade antibodies generated by vaccines or prior infections, researchers said.

California's strain — B.1.427/B.1.429 — currently makes up 50 percent of all cases in the state.

By the end of next month, the strain will probably account for 90 percent of the state's coronavirus infections, Dr Charles Chiu, a researcher on the study and a virologist at the University of California, San Francisco, told the Los Angeles Times.

However, just like most states in the US, California continues to see big declines in COVID-19 after the recent holiday surge. The state is now recording about 6,000 new coronavirus cases a day, down from 45,000 a day from six weeks ago.

"Even when we're seeing a surge of cases due to this variant, overall, the cases have been going down since the holidays," Chiu told The Washington Post. "We're not seeing the surge we might be worried about."

Many concerns have focused on whether variants could reduce the effectiveness of vaccines. The new study found that the California strain partially impedes the effectiveness of antibodies. But the reduction was modest. Current vaccines still afford protection, particularly against severe disease.

The B.1.1.7 variant, which was first identified in the UK, currently accounts for about 2,000 cases in 45 states. As of Wednesday, officials said the UK variant made up about 6.2 percent of cases in the second week of February.

The UK variant is doubling in the US every 10 days and is expected to become the most prevalent form of coronavirus in the US by the end of March.

Preliminary evidence suggests that B.1.1.7, the UK variant, is about 35 percent more deadly than other variants. But testing suggests that the vaccines still work well against this variant.




15601673666 胡女士


18049721407 梁工




  • 2021潮流服装消费趋势报告(CBNData)
    CBNData联合淘宝直播ON MAP发布《2021潮流服装报告》,基于CBNData消费大数据,洞察在国潮、奥运主题大热的情况下,2021年潮流服装如何寻求增长。
  • 2021防晒趋势白皮书(CBNData)
  • 2.4亿人想穿,一年订单猛涨133%,被嫌弃的黑丝又翻红了(CBNData)
  • 淘宝直播2021年度报告(CBNData)
    2020年,直播进入了快速普及阶段,各个新品牌也纷纷开始带货。直播电商下半场,用户价值在何处?淘榜单、淘宝直播联合淘宝直播ON MAP推出的《淘宝直播2021年度报告​》,对淘宝直播的用户商业价值和货品品类进行了分析,以便品牌和商家了解行业新趋势。
  • 2021精致妈妈生活及消费趋势洞察(CBNData)
  • 2021中国消费品牌发展报告(CBNData)
  • 2022春夏上海时装周作品发布报名通道开启
    2022春夏上海时装周作品发布报名通道开启 ,可扫描二维码了解详情。
  • 如何快速有效地鉴别 纺纱工艺与纱线品种
  • 什么是天丝纱​?天丝纱的性能与特点​
    tencel(天丝)纤维是英国acocdis公司生产的lyocell纤维的商标名称,在我国注册中文名为"天丝",该纤维以木浆为原料经溶剂纺丝方法生产的一种崭新的纤维。它有棉的“舒适性、涤纶的“强度”、毛织物的“豪华美感”和真丝的“独特触感”及“柔软垂坠” ,无论在干或湿的状态下,均极具韧性。